SNHG15 aids SARS-CoV-2 entry via RABL2A

References

• Ghebreyesus TA. WHO director-general’s opening remarks at the media briefing on COVID-19. WHO Director General’s Speeches. 2020 [11 March 2020];4. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020
   Google Scholar
• Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nature Rev Microbiol. 2021;19(3):141–154. doi: 10.1038/s41579-020-00459-7
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• WHO Coronavirus (COVID-19) dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data. https://covid19.who.int/.
   Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi: 10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• V’kovski P, Kratzel A, Steiner S, et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155–170. doi: 10.1038/s41579-020-00468-6
   PubMed Web of Science ®Google Scholar
• Gui M, Song W, Zhou H, et al. Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res. 2017;271(1):119–129. 2016. doi: 10.1038/cr.2016.152
   Google Scholar
• Huang Y, Yang C, Xu X, et al. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;419(41):1141–1149. doi: 10.1038/s41401-020-0485-4
   Google Scholar
• Bestle D, Heindl MR, Limburg H, et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance. 2020;3(9):e202000786. doi: 10.26508/lsa.202000786
   PubMed Web of Science ®Google Scholar
• Yuan M, Wu NC, Zhu X, et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science (80). 2020;368(6491):630–633. doi: 10.1126/science.abb7269
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271. doi: 10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci. 2020;117(21):11727–11734. doi: 10.1073/pnas.2003138117
   PubMed Web of Science ®Google Scholar
• D W, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCov spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi: 10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Evans JP, Liu S-L. Role of host factors in SARS-CoV-2 entry. J Biol Chem. 2021;297(1):100847. doi: 10.1016/j.jbc.2021.100847
   PubMed Web of Science ®Google Scholar
• Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science (80-). 2020;370(6518):861–865. doi: 10.1126/science.abd3072
   PubMed Web of Science ®Google Scholar
• Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (80-). 2020;370(6518):856–860. doi: 10.1126/science.abd2985
   PubMed Web of Science ®Google Scholar
• Clausen TM, Sandoval DR, Spliid CB, et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell. 2020;183(4):1043–1057.e15. doi: 10.1016/j.cell.2020.09.033
   PubMed Web of Science ®Google Scholar
• Zhang Q, Chen CZ, Swaroop M, et al. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. Cell Discov. 2020;61(1):1–14. doi: 10.1038/s41421-020-00222-5
   Google Scholar
• Wang K, Chen W, Zhang Z, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;51(5):1–10.
   Google Scholar
• Wang S, Qiu Z, Hou Y, et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 2021;312(2):126–140. doi: 10.1038/s41422-020-00460-y
   Google Scholar
• Bayati A, Kumar R, Francis V, et al. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J Biol Chem. 2021;296:100306. doi: 10.1016/j.jbc.2021.100306
   PubMed Web of Science ®Google Scholar
• Klein S, Cortese M, Winter SL, et al. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat Commun. 2020;111(1):1–10. doi: 10.1038/s41467-020-19619-7
   Google Scholar
• Kesheh MM, Mahmoudvand S, Shokri S. Long noncoding RNAs in respiratory viruses: A review. Rev Med Virol. 2022;32(2):e2275. doi: 10.1002/rmv.2275
   PubMed Web of Science ®Google Scholar
• Melissari MT, Grote P. Roles for long non-coding RNAs in physiology and disease. Pflugers Archiv Eur J Physiol. 2016;468(6):945–958. doi: 10.1007/s00424-016-1804-y
   PubMed Web of Science ®Google Scholar
• Ding Y-Z, Zhang Z-W, Liu Y-L, et al. Relationship of long noncoding RNA and viruses. Genomics. 2016;107(4):150–154. doi: 10.1016/j.ygeno.2016.01.007
   PubMed Web of Science ®Google Scholar
• Bamunuarachchi G, Pushparaj S, Liu L. Interplay between host non-coding RNAs and influenza viruses. RNA Biol. 2021;18(5):767–784. doi: 10.1080/15476286.2021.1872170
   PubMed Web of Science ®Google Scholar
• More S, Zhu Z, Lin K, et al. Long non-coding RNA PSMB8-AS1 regulates influenza virus replication. RNA Biol. 2019;16(3):340–353. doi: 10.1080/15476286.2019.1572448
   PubMed Web of Science ®Google Scholar
• Vishnubalaji R, Shaath H, Alajez NM. Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response. Genes (Basel). 2020;11(7):760. 11, 760. doi: 10.3390/genes11070760
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhao T, Deng R, et al. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood. Sci Rep. 2021;11(1):1–14. doi: 10.1038/s41598-021-86134-0
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Banerjee B, Karasik D, et al. mRNA-lncRNA co-expression network analysis reveals the role of lncRNAs in immune dysfunction during severe SARS-CoV-2 infection. Viruses. 2021;13(3):402. doi: 10.3390/v13030402
   PubMed Web of Science ®Google Scholar
• Turjya RR, Khan MAAK, Mir Md Khademul Islam AB. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection. Future Virol. 2020;15(9):577–593. doi: 10.2217/fvl-2020-0188
   PubMed Web of Science ®Google Scholar
• Yang Q, Lin F, Wang Y, et al. Long noncoding RNAs as emerging regulators of COVID-19. Front Immunol. 2021;12. doi: 10.3389/fimmu.2021.700184
   Web of Science ®Google Scholar
• Lamers MM, van der Vaart J, Knoops K, et al. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. Embo J. 2021;40(5):e105912. doi: 10.15252/embj.2020105912
   PubMed Web of Science ®Google Scholar
• Saeinasab M, Bahrami AR, González J, et al. SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF. J Exp Clin Cancer Res. 2019;381(1):1–16. doi: 10.1186/s13046-019-1169-0
   Google Scholar
• Tong J, Ma X, Yu H, et al. SNHG15: a promising cancer-related long noncoding RNA. Cancer Manag Res. 2019;11:5961–5969.
   PubMed Web of Science ®Google Scholar
• Shuai Y, Ma Z, Lu J, et al. LncRNA SNHG15: A new budding star in human cancers. Cell Proliferation. 2020;53(1). doi: 10.1111/cpr.12716
   Web of Science ®Google Scholar
• Ma Z, Huang H, Wang J, et al. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget. 2017;8(48):84153–84167. doi: 10.18632/oncotarget.20359
   PubMedGoogle Scholar
• Spearman P. Viral interactions with host cell Rab GTPases. Small GTPases. 2018;9(1–2):192. doi: 10.1080/21541248.2017.1346552
   PubMedGoogle Scholar
• Agola J, Jim P, Ward H, et al. Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet. 2011;80(4):305. doi: 10.1111/j.1399-0004.2011.01724.x
   PubMed Web of Science ®Google Scholar
• Nakayama K, Katoh Y. Ciliary protein trafficking mediated by IFT and BBSome complexes with the aid of kinesin-2 and dynein-2 motors. J Biochem. 2018;163(3):155–164. doi: 10.1093/jb/mvx087
   PubMed Web of Science ®Google Scholar
• Nishijima Y, Hagiya Y, Kubo T, et al. RABL2 interacts with the intraflagellar transport-B complex and CEP19 and participates in ciliary assembly. Mol Biol Cell. 2017;28(12):1652–1666. doi: 10.1091/mbc.e17-01-0017
   PubMed Web of Science ®Google Scholar
• Kanie T, Abbott KL, Mooney NA, et al. The CEP19-RABL2 GTPase complex binds IFT-B to initiate intraflagellar transport at the ciliary base. Dev Cell. 2017;42(1):22–36.e12. doi: 10.1016/j.devcel.2017.05.016
   PubMed Web of Science ®Google Scholar
• Silva-Ayala D, López T, Gutiérrez M, et al. Genome-wide RNAi screen reveals a role for the ESCRT complex in rotavirus cell entry. Proc Natl Acad Sci. 2013;110(25):10270–10275. doi: 10.1073/pnas.1304932110
   PubMed Web of Science ®Google Scholar
• Crawford KHD, Eguia R, Dingens AS, et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses. 2020;12(5):513. doi: 10.3390/v12050513
   PubMed Web of Science ®Google Scholar
• Senavirathna LK, Huang C, Pushparaj S, et al. Hypoxia and transforming growth factor β1 regulation of long non-coding RNA transcriptomes in human pulmonary fibroblasts. Physiol Rep. 2020;8(1). doi: 10.14814/phy2.14343
   PubMed Web of Science ®Google Scholar
• Huang CH, Liang Y, Zeng X, et al. Long noncoding RNA FENDRR exhibits antifibrotic activity in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2020;62(4):440–453. doi: 10.1165/rcmb.2018-0293OC
   PubMed Web of Science ®Google Scholar